About

Provided by Ecija Abogados

Four partners and 10 fee earners in the Dominican Republic. ECIJA is one of the leading players in the corporate and commercial practice, offering outstanding expertise on M&A, financial services, capital markets, foreign investments and commercial transactions. Among the top 10 firms in the country ranked as leading firm in the corporate practice by the most relevant publications.

-          Advice to Pfizer in connection with:  the local due diligence and implementation of the acquisition of Hospira and the local implementation of the sale of the Hospira to ICU Medical, as part of a 1-billion-dollar transaction.

-          Representation of Kohlberg Kravis Roberts in connection with the local implementation of the acquisition of the Flora Food Group from Unilever, as part of an 8-billion-dollar transaction.

-          Advice to Stewart Title Latin America, as collateral agent, in connection with the default of the 2016 Recovery Notes and the 2016 Senior Notes issued by Cap Cana, S.A. under Regulation 144A. This is the largest transaction of its nature in the Dominican Republic to date.

Key Clients: Pfizer CAC, Kohlberg Kravis Roberts, Falconbridge Dominicana

Chambers Review

Provided by Chambers

Corporate/Commercial - Dominican Republic

4
Band 4

What the Team is Known For

ECIJA possesses a key corporate and commercial practice with significant activity in the financial arena, advising on loan agreements, securities issuances and regulatory approvals. The team also assists with M&A transactions and joint venture agreements. The firm's client roster includes notable investment groups and corporations.

Key contact

Polibio Valenzuela Scheker and Gabriel Dejarden are the key client contacts at the firm.

Work Highlights

  • ECIJA assisted Finisterre Capital with structuring, negotiating and forming multiple private equity funds structured as real estate development trusts.

Strengths

Provided by Chambers